Error: Could not add to watchlist. X

Biota Pharmaceuticals Inc

+ Watchlist
NABI:US
Ticker Change
NABI:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
10.80
Volume
0
Previous Close
10.80
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
28.328
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
ADDRESS
12270 Wilkins Avenue
Rockville, MD 20852
United States
PHONE
1-301-770-3099
  • Russell H Plumb
    Chairman
  • Peter Azzarello
    Chief Accounting Officer
  • Joseph M Patti
    President/CEO
Show More